(Date:11/10/2009)... iSirona Appoints John Cooper as Chairman of... Fla. (PRWEB) November 10, 2009 -- iSirona®, a... for healthcare providers, today announced the app...effective October 21, 2009. He replaces Chairman D... serve as the company,s CEO and retains a seat on ...
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yongye Inter...Company") a leading manufacturer, developer,and di...trient products in the,People,s Republic of China ...erence call at 10:00 a.m. Eastern Time (11:00 p.m....cuss results for the quarter ended September 30, 2...
(Date:11/9/2009)...Nov. 9 CEL-SCI Corporati...neth S. Rosenthal, Professor of Immunology and Mic...e of Medicine and Pharmacy, reported on work condu...land Clinic and CEL-SCI on CEL-SCI,s LEAPS vaccine...Cbio Vaccine: "All Things Considered" Conference i...
(Date:11/8/2009)...IEW, Calif. Nov. 5, 2009 Complete Genomics, a th...day announced publication of a report in the journ...cing platform, including analysis of sequence data...s cost for these three genomes sequenced on the pr...m $8,005 for 87x coverage to $1,726 for 45x covera...
Breaking Biology Technology:iSirona Selects New Chairman of the Board 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2...Laboratories,Holdings, Ltd., a wholly owned subsid...nnounced today that it and Mylan Inc. (NYSE: MYL ...mercialize, develop and,distribute the novel beta ...ly approved in the United States for the treatment...orest will assume Mylan,s commercial rights,for By...
...accinogen, Inc. announced that,its new vaccine to ...ally,available in Europe starting June 2008., "Th... viable vaccine,for colon cancer," said Dr. Michae...en. "It is the beginning of our worldwide strategy...ibility of patient specific anti-cancer,therapies ...
...Pharmasset, Inc.,(Nasdaq: VRUS ) management will ...nual SIGnificant Investment Options in Healthcare ...el in New York, NY. Schaefer Price,Pharmasset,s Ch... the,company on Wednesday, March 5, 2008 from 2:00...m. In addition, Dr. Michelle Berrey, Pharmasset,s,...
Other Biology Technology:Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement 2Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement 3Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year 2Pharmasset to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th 2(Date:11/8/2009)...YETTE, Ind. - Researchers at Purdue University hav...nerve fibers in spinal cord injuries using nano-sp...y after an accident. , The synthetic "copolymer ...eters in diameter, or roughly 100 times smaller th...rs have been studying how to deliver drugs for can...
(Date:11/6/2009)... the 150th anniversary this month of the publicati...tute of Biological Sciences (AIBS) is publishing o...s Darwin and his historic insights into evolution....iversity of California, Berkeley, and James T. Cos...e, "Ten Myths About Charles Darwin," appeared in t...
(Date:11/5/2009)... Association of Biology Teachers (NABT) will recog... sciences at Naugatuck Valley Community College (N...ution Education Award during the NABT annual profe...vember 2009 in Denver, Colorado. , The Evolution...stitute of Biological Sciences,(AIBS) and Biologi...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 1U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 3Zeus Increases Its Presence in Aerospace Industry with AS9100 Certification 14665 1Zeus Increases Its Presence in Aerospace Industry with AS9100 Certification 14665 2...a;-1, clone C464.6 GenBank Accession Number : NM_...isolated from membrane fractions of rabbit kidney ....4, 0.15M NaCl containing 0.05% sodium azide Quali... rat brain microsomal preparations Recognizes &alp...
Mouse Anti-Human PSGL-1 Monoclonal Antibody, Unconjugated, Clone 215 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Adenovirus Type 7 hexon C11 Monoclonal Antibody, Unconjugated, Clone 1-N-14 from GeneTex
Mouse Anti-20S proteasome subunits alpha 1 Monoclonal Antibody, Unconjugated, Clone MCP231 from Upstate
Biology Products: